FDA approves new drug, Beyfortus, to protect toddlers and babies against RSV
The monoclonal antibody, called Beyfortus, is the first of its kind likely to be available beyond a small population of immunocompromised children.
Related Articles
65 Million People Suffer From Long Covid. Our Experts Say New Vaccines Are The Best Defense
Updated Covid vaccines based on Nobel prize-winning mRNA technology provide added protection — especially important when Covid-19, flu and RSV infections spike.
‘Tis The Season — Why Influenza And Covid-19 Surge In The Winter
For centuries, we’ve known that certain viral infections peak during winter months. But why is there seasonality associated with some diseases?
TikTok is a trap. As a doctor, I tell parents to protect their kids from social media.
With increased rates of anxiety and unhappiness among our teens tied directly to social media overuse, it is long past time to do something about…
SARS-CoV-2, the virus behind COVID-19, can infect sensory neurons
When COVID-19 began spreading in 2020, some of its most common symptoms affected the peripheral nervous system, the network of nerves that enables communication between…
Midwesterners are seeing smoke again, NY is next: How you can prepare your home.
With the recent wildfires in Canada impacting the air in the Midwest and Northeast and the wildfires that burn in the West, experts offer tips…
CDC report: People and animals are increasingly getting sick from toxic algae
A new federal report says more people and animals, including beloved pets, are getting sick and dying from exposure to toxic algae.
Crucial defense bill won’t pass with controversial amendments, national security official warns
National security adviser Jake Sullivan said the House GOP version of the annual defense bill has no chance of getting to President Joe Biden’s desk.
Britain on lockdown alert as new killer virus which kills 40% of victims ‘certain’ to reach UK
‘Risk of spread’ warning over CCHF which causes severe viral haemorrhagic fever outbreaks